Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pivotal Phase III Trial to Investigate the Efficacy and Safety of an Orodispersible Tablet Vardenafil Versus Placebo in the Treatment of Men With Erectile Dysfunction (ED) - a Fixed-dose, Double-blind, Randomized Multi-center Trial

NCT00655629 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00655629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00655629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pivotal Phase III Trial to Investigate the Efficacy and Safety of an Orodispersible Tablet Vardenafil Versus Placebo in the Treatment of Men With Erectile Dysfunction (ED) - a Fixed-dose, Double-blind, Randomized Multi-center Trial
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2008
Completion date
February 28, 2009
Enrollment
339 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

erectile dysfunction